A composition containing sporopollenin is disclosed which is characterized in that it is present as a solution and, aside from 0.01% to 12% by weight, preferably 0.1% to 5% by weight, of sporopollenin, it also contains 0.01% to 17% by weight, preferably 0.1% to 10% by weight, of at least one emulsifier, it also contains 71.00% to 99.98% by weight, preferably 85% to 99.80% by weight, of at least one hydrophilic solvent, and the use of this composition for cosmetic, pharmaceutical purposes, as chelating agents and nutritional supplements is also disclosed.

 
Web www.patentalert.com

> Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment

~ 00327